Search

everythinglearnresearchcommunity

for

Search:↓

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

People with androgenetic alopecia may have a higher genetic risk for cardiovascular diseases.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Early diagnosis and genetic counseling are crucial for managing adrenoleukodystrophy.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Upadacitinib improved multiple immune-related conditions in one patient.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

AP-1 controls tumor cell type by affecting key signaling pathways.

No clear link between specific gene and hair loss in Mexican brothers.

People with severe hair loss (Alopecia Areata) have different scalp bacteria than healthy people, which might help predict the condition's progress.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

A specific gene mutation causes congenital hair loss.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Tofacitinib helped regrow hair in a teen with a unique pattern of alopecia areata.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

CARASIL, a rare genetic disorder, was confirmed in an Arabic woman, highlighting its rarity and need for stroke prevention.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Proteins from Tianshan red deer abomasum have strong anti-inflammatory, anti-tumor, and antioxidant effects.

Alopecia areata progression is linked to stress and hormone changes, suggesting new treatment targets.

CSLD1 suppresses rice root hair growth with NH4+ and regulates AMT1;2 expression.